A major advance in cancer research is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This vital malignant inhibitor protein is frequently lost in several forms of cancer, leading uncontrolled https://bookmarkssocial.com/story21869002/nanobodies-reactivate-p53-a-promising-pathway-for-tumor-therapy